UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1943-01-01

Employees: 8.1K

Market Cap: -

Website: http://www.utsouthwestern.edu

Clinical Trials

Comparing Virtual Reality (VR) to Non-VR for Decreasing Preoperative/Procedural Anxiety

Not Applicable

Completed

Conditions: Preoperative Anxiety

Interventions: Other: Virtual reality

First Posted Date: 2021-10-26

Last Posted Date: 2025-01-01

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 89

Registration Number: NCT05094141

Locations: 🇺🇸
Kiley Poppino, Dallas, Texas, United States

Brain Metabolism Observed at 7 Tesla

Recruiting

Conditions: Glut1 Deficiency Syndrome 1, Autosomal Recessive
Glucose Metabolism Disorders
Glucose Transport Defect
Glucose Transporter Type 1 Deficiency Syndrome
Epilepsy
Glut1 Deficiency Syndrome 1
Glucose Transporter Protein Type 1 Deficiency Syndrome

Interventions: Device: Magnetic resonance imaging

First Posted Date: 2021-10-20

Last Posted Date: 2023-10-25

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 20

Registration Number: NCT05085704

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Assessment Skin Quality and Efficacy of Dermal Line After Four Bipolar Radiofrequency Microneedling Treatments

Not Applicable

Completed

Conditions: Aging

Interventions: Device: InMode Morpheus8 System

First Posted Date: 2021-10-20

Last Posted Date: 2023-10-31

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 13

Registration Number: NCT05085730

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

Vitamin D Deficiency in Adults Following a Major Burn Injury

Phase 4

Recruiting

Conditions: Vitamin D Deficiency
Burns

Interventions: Drug: Ergocalciferol Capsules

First Posted Date: 2021-10-19

Last Posted Date: 2024-10-18

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 70

Registration Number: NCT05084248

Locations: 🇺🇸
Parkland Health and Hospital Systems, Dallas, Texas, United States

Premedication for Less Invasive Surfactant Administration Study (PRELISA)

Phase 4

Recruiting

Conditions: Respiratory Distress Syndrome, Newborn

Interventions: Drug: IV Normal Saline Placebo Arm
Drug: IV Atropine and Fentanyl Premedication Arm

First Posted Date: 2021-10-04

Last Posted Date: 2024-06-13

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 58

Registration Number: NCT05065424

Locations: 🇺🇸
Parkland Health and Hospital System, Dallas, Texas, United States

Surgical Window of Opportunity Study of Orally Administered BAY 2402234 in Recurrent Glioma

Early Phase 1

Withdrawn

Conditions: IDH Mutation
Glioma

Interventions: Drug: BAY 2402234

First Posted Date: 2021-09-29

Last Posted Date: 2022-01-11

Lead Sponsor: University of Texas Southwestern Medical Center

Registration Number: NCT05061251

Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets

Phase 2

Recruiting

Conditions: Major Depressive Disorder
Healthy Controls

Interventions: Drug: Midazolam injection
Drug: Ketamine Hydrochloride

First Posted Date: 2021-09-16

Last Posted Date: 2024-05-07

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 180

Registration Number: NCT05046184

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

Effect of SGLT2i on Cardiovascular Biomarkers in Patients With Type 2 Diabetes and CKD Stage 3b-4

Recruiting

Conditions: Diabetes
Kidney Disease, Chronic

Interventions: Drug: SGLT2 inhibitor

First Posted Date: 2021-09-02

Last Posted Date: 2024-12-30

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 28

Registration Number: NCT05033054

Locations: 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

Phase 1

Recruiting

Conditions: HER2-negative Breast Cancer
Metastatic Breast Cancer

Interventions: Drug: PLD Chemotherapy
Drug: CDX-1140
Drug: CDX-301

First Posted Date: 2021-09-01

Last Posted Date: 2024-11-14

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 30

Registration Number: NCT05029999

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States
🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
🇺🇸
Sarah Cannon Research Institute, Nashville, Tennessee, United States

and more 4 locations

Force Modulating Tissue Bridges for Closure of Vertical Scars in Breast Reduction

Not Applicable

Active, not recruiting

Conditions: Surgical Incision

First Posted Date: 2021-08-31

Last Posted Date: 2024-05-31

Lead Sponsor: University of Texas Southwestern Medical Center

Target Recruit Count: 42

Registration Number: NCT05028816

Locations: 🇺🇸
UT Southwestern Medical Center- Outpatient Building, Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy